#34Health Care· Health Care Facilities

UHSStrong Buy

Universal Health Services

$168.64USD

Composite Score63.9Strong

+32

Margin of safety+32%Undervalued

Fair value$248.07

Target$645.33

Loss chance24%

Price (1y)

Loading price history…

Fair price check

6 different valuation methods each estimate what UHS should be worth, then we compare to today's price.

Looks undervalued

Models suggest UHS is trading below fair value

Today's price

$168.64

Median fair price

$248.07

+47% vs today

Of 5 methods:3 say cheap2 say pricey(1 outlier excluded)

EV/EBITDAUndervalued
thinks it's a bargain — estimates $645.33, about 283% above today
P/E multiplesUndervalued
thinks it's a bargain — estimates $595.73, about 253% above today
P/B multiplesUndervalued
thinks it's a bargain — estimates $351.97, about 109% above today
Graham (defensive)Overvalued
thinks it's expensive — estimates $144.18, about 15% below today
Residual IncomeOvervalued
thinks it's expensive — estimates $73.40, about 56% below today
DCF (2-stage)Outlier
estimate looks unreliable — estimates $23.45 — likely unreliable

How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.

Fair price ensemble

Median fair

$248.07

Margin of safety

+32.0%

Max (ex-outliers)

$645.33

Tangible BVPS

$55.27

Method	Value
Graham (defensive)	$144.18
P/E multiples(vs sector peers)	$595.73
P/B multiples(vs sector peers)	$351.97
EV/EBITDA(vs sector peers)	$645.33
Residual Income	$73.40
DCF (2-stage)	$23.45

goodwill heavy
extreme dcf estimate

Median of all applicable methods (current price $168.64). Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.

Pillar breakdown

8 dimensions, each scored 0–100 against the universe

Health Care median (n=59)

Quality
Profit margins & asset efficiency
64
Decent
Value
Price vs fundamentals
91
Strong
Growth
Revenue & earnings trajectory
83
Strong
Momentum
Recent price strength
14
Poor
Health
Balance sheet & solvency
56
Decent
Profitability
ROE, ROA, ROIC
53
Decent
Technical
Trend & volatility signals
65
Decent
Risk
Volatility & drawdown profile
39
Weak

0305070100

Strong (70+)Decent (50–70)Weak (30–50)Poor (<30)

Pillars not shown: Sentiment, ML (Phase 5+).

Raw fundamentals (SEC EDGAR)

Metric	Value
Market cap	$10.40B
Revenue (TTM)	$17.76B
Net income (TTM)	$1.55B
Operating cash flow (TTM)	$1.91B
CapEx (TTM)	$993.28M
Free cash flow (TTM)CFO − CapEx	$912.69M
Total assets	$15.68B
Total liabilities	N/A
Stockholders' equity	$7.46B
Cash & equivalents	$119.03M
Shares outstanding	61.67M
EPS (basic)	$5.71
EPS (diluted)	$5.65
P/E ratio (TTM)	6.72

TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).

Data quality

Latest filed date: 2026-05-07
Latest period end: 2026-03-31
Filing lag: 9 days
Missing metrics: 6(total_liabilities, gross_profit, cost_of_revenue, research_and_development, sga_expense, inventory)

Phase 3c — composite is the 8-pillar weighted score over quality, value, growth, momentum, health, profitability, technical, and risk. Sentiment + ML pillars land in Phases 5-6; until then their weight redistributes pro-rata. Fair price is the median of 6 valuation methods (Graham, P/E / P/B / EV-EBITDA multiples, RIM, DCF) with outliers above 5× current price excluded from the max. Risk-overlay flags annotate only — they suppress the entered-top-5 badge but do not modify the composite.